利特昔替尼在国内多少钱一盒

Introduction: Ritexitinib is a new drug for the treatment of alopecia areata, which provides new ideas for the treatment of various autoimmune diseases. Its price and medication guidelines have become the focus of many patients. This article will introduce in detail the domestic price situation, medication guidance and contraindication groups of ritexitinib to help readers better understand this drug.

How much does a box of ritexitinib cost in China

Price of the original drug

The original drug has been launched in China, with a price of about US$387 per box, each box containing 50mg*30 tablets.

Price of generic drugs

The price of the generic version of ritexitinib produced by Lucius in Laos is relatively low, about US$133 per box, and each box is 50mg*28 pills. Generic drugs are basically the same as the original drugs in terms of ingredients and effects, but are more affordable.

Purchase channel selection

Whether it is original medicine or generic medicine, it can be purchased through regular hospitals or pharmacies. For patients with limited financial conditions, choosing generic drugs can reduce their burden and at the same time obtain effective treatment.

Ritexitinib Medication Guide

Usage

The use of ritexitinib must strictly follow the doctor's recommendations. Under normal circumstances, the recommended daily dose for adults is 50mg, and the specific dosage may be adjusted according to the condition. Patients should take it on time and in the right amount, and avoid increasing or decreasing the dose at will.

Precautions

During the period of taking, patients should pay attention to observe their physical condition, record any symptoms of discomfort, and provide timely feedback to the doctor. Regular review will help monitor the effect and side effects of the drug, thereby adjusting the treatment plan.

Contraindicated groups for ritexitinib

Those allergic to drug ingredients

People with a history of allergies to ritixitinib or its excipients should not use this drug. Allergic reactions may cause serious health problems, so such patients should avoid contact with this drug.

Pregnant and lactating women

There is insufficient safety data of ritexitinib in pregnant women to clarify its potential risks to the fetus or mother, such as birth defects, miscarriage, etc. Pregnant and lactating women should seek professional advice before using ritexitinib. There is currently insufficient data on the safety of this drug in this population, so its use without evaluation is not recommended.

Patients with specific diseases

Patients with certain specific diseases, such as severe liver and renal insufficiency, need to be extra cautious when using ritexitinib. Such patients have poor metabolism, which may lead to drug accumulation in the body and increase the risk of adverse reactions.

When deciding whether to use ritexitinib, patients should comprehensively consider personal health status, financial ability and other factors, and use the drug rationally under professional guidance.